Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate for IOP Control during Intubation
NCT01241175Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of magnesium sulfate in ocular hypertension (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Intra ocular pressure. Status: completed.
02
Drugs
magnesium sulfate
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on NCT01241175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01241175.